Melchor Demetria
Overview
Explore the profile of Melchor Demetria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agrawal R, Majeed M, Attar B, Flores E, Haque Z, Aqeel S, et al.
Transl Gastroenterol Hepatol
. 2022 Mar;
7:4.
PMID: 35243113
Background: An adequate bowel preparation prior to colonoscopy is a major quality-limiting factor that determines both the diagnostic and therapeutic yield of a colonoscopy. Colonoscopy is considered the gold standard...
2.
Mutneja H, Bhurwal A, Attar B, Vohra I, Palomera Tejeda E, Verma S, et al.
Eur J Gastroenterol Hepatol
. 2021 Jul;
33(1S Suppl 1):e71-e77.
PMID: 34284413
We aimed to conduct a systematic review and meta-analysis on the efficacy and safety of primary needle-knife fistulotomy (NFK) in biliary cannulation. An electronic bibliographic search of digital dissertation databases...
3.
Vohra I, Attar B, Haghbin H, Mutneja H, Katiyar V, Sharma S, et al.
Eur J Gastroenterol Hepatol
. 2021 May;
33(9):1174-1184.
PMID: 34034271
Background And Study Aim: Ulcerative colitis (UC) is a chronic relapsing and remitting disease requiring frequent hospitalization. Biologics have become the recommended initial therapy for Biologics in patients with moderate...
4.
Flores Cordova E, Mathew M, Mutneja H, Caldito E, Demetria M
Cureus
. 2020 Aug;
12(6):e8913.
PMID: 32742879
Kaposi sarcoma is one of the acquired immunodeficiency syndrome (AIDS) defining diseases. AIDS-associated Kaposi sarcoma affects primarily the skin and the lungs. Although gastrointestinal involvement is relatively common, biliary tract...
5.
Kotwal V, Mbachi C, Wang Y, Attar B, Randhawa T, Flores E, et al.
Dig Dis Sci
. 2020 Jul;
66(6):2084-2091.
PMID: 32648078
Background And Aims: Several criteria have been described to noninvasively predict the presence of high-risk esophageal varices in patients with compensated advanced chronic liver disease (cACLD). However, a recent study...
6.
Wang Y, Attar B, Agrawal R, Vohra I, Farooq M, Aqeel S, et al.
J Gastrointest Cancer
. 2020 May;
52(2):523-528.
PMID: 32405967
Background: Advanced liver fibrosis and cirrhosis represent independent risk factors for hepatocellular carcinoma (HCC). There is also evidence suggesting that several etiologies of chronic liver disease elevate the risk for...
7.
Vohra I, Attar B, Katiyar V, Palacios P, Randhawa T, Baig M, et al.
J Gastrointest Cancer
. 2020 Mar;
52(1):201-206.
PMID: 32128703
Purpose Of The Study: Hepatocellular carcinoma (HCC) has tripled in incidence over the past 20 years and now ranks as the third leading cause of mortality attributed to cancer. Underlying...
8.
Majeed M, Agrawal R, Attar B, Kamal S, Patel P, Abu Omar Y, et al.
Eur J Gastroenterol Hepatol
. 2019 Dec;
32(2):193-198.
PMID: 31851082
Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine. However, recent literature has drawn attention to the limitations of using P-value to report statistical significance of outcomes in the...
9.
Agrawal R, Majeed M, Attar B, Abu Omar Y, Chimezi M, Patel P, et al.
Ann Gastroenterol
. 2019 Nov;
32(6):642-649.
PMID: 31700243
Background: In 2012, the American Association for the Study of Liver Diseases published practice guidelines for the management of patients with ascites caused by cirrhosis, using data from randomized controlled...
10.
Agrawal R, Majeed M, Attar B, Abu Omar Y, Mbachi C, Wang Y, et al.
Ann Gastroenterol
. 2019 Sep;
32(5):489-497.
PMID: 31474796
Background: Ursodeoxycholic acid (UDCA) and obeticholic acid are currently approved treatments for primary biliary cholangitis (PBC). Since some patients do not respond adequately to UDCA, other therapies, such as bezafibrate,...